NovaBay Pharmaceuticals, Inc., an advanced clinical-stage biopharmaceutical company developing anti-microbial products, today announced positive top-line results from its recently completed Phase 2 ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay ® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today ...
The objectives of this study are to evaluate catheter flow rate reduction, early removal of catheters due to clinical blockage as well as safety and tolerability of AIS. In September 2013 NovaBay ...
Authors of a research letter in this week's issue of THE LANCET propose a new method for inflating urinary catheters-which could avoid common problems of encrustration and blockage of the catheter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results